CClinicalTrials.gg
CompletedNCT07134959Updated Jan 22, 2026

Exercise Benefits and Barriers in Pregnancy

An observational study in Pregnancy, sponsored by Ordu University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by Ordu University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
300
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The aim of this study is to examine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women. It will contribute to raising awareness about engaging in physical activity and exercise during pregnancy in the pregnant population through the applied questionnaires.

Read the detailed description

Regular physical activity (PA) and exercise during pregnancy help protect the health of both the mother and the baby by reducing the risk of excessive gestational weight gain, hypertension, gestational diabetes, venous problems, and birth-related complications. They also have positive effects on sleep, stress, anxiety, depression, and overall quality of life. However, PA participation rates during pregnancy are low and tend to decline as pregnancy progresses through the trimesters. Hormonal and physiological changes, weight gain, fatigue, and psychological disturbances are among the main factors limiting participation. Therefore, identifying the barriers to PA during pregnancy and developing strategies to address them is essential. Assessing perceptions of the benefits and barriers to exercise can guide interventions aimed at increasing PA levels. This study aims to determine the validity and reliability of the Exercise Benefits/Barriers Scale in pregnant women, with the expectation that its findings will provide valuable evidence for both scientific research and clinical practice.

02

Conditions studied

  • Pregnancy

Browse trials for

Keywords

  • pregnancy
  • exercise
  • Questionnaire
  • physical activity
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 300 is above the median of 100 across 292 observational studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Ordu University is the lead sponsor of 31 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Ordu University Training and Research Hospital

Eligibility criteria

Inclusion Criteria for Study Group:

  1. Being between 18 and 45 years of age,
  2. Being in the second or third trimester of pregnancy,
  3. Being literate in Turkish,
  4. Willingness to participate in the study.

Exclusion Criteria for Study Group:

  1. Presence of pregnancy complications that may prevent physical activity and exercise (e.g., preeclampsia, vaginal bleeding, heart disease),
  2. Presence of orthopedic or neurological problems that may hinder participation in the study,
  3. Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
  4. Multiple pregnancy.

Inclusion Criteria for Control Group:

  1. Being between 18 and 45 years of age,
  2. Female sex,
  3. Being literate in Turkish,
  4. Willingness to participate in the study.

Exclusion Criteria for Control Group:

  1. Having a disease severe enough to prevent physical activity and exercise (e.g., endocrine and metabolic disorders, cardiopulmonary diseases),
  2. Presence of orthopedic or neurological problems that may hinder participation in the study,
  3. Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
  4. Participation in another experimental or drug study during the study period,
  5. Being pregnant or suspected of pregnancy,
  6. Having experienced pregnancy, childbirth, or surgical intervention within the last six months.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
300 participants (actual)
Target follow-up
5 Days
Patient registry
Yes

Groups and cohorts

  • study group

    pregnant women

  • control group

    healthy non-pregnant women

06

What researchers measure

Primary outcomes

  1. Exercise Benefits/Barriers Scale (EBBS):

    Developed in 1987 by Sechrist et al. to assess individuals' perceptions of the benefits of and barriers to exercise (Sechrist et al., 1987). It is a Likert-type scale with responses rated from "4 = strongly agree" to "1 = strongly disagree." The scale consists of two subscales: EBBS-Benefits and EBBS-Barriers. The EBBS-Benefits subscale contains 29 items, while the EBBS-Barriers subscale contains 14 items. In the EBBS-Barriers subscale, lower scores indicate a higher perceived barrier to exercise, whereas in the EBBS-Benefits subscale, higher scores indicate a more positive perception of exercise. The validity and reliability of the Turkish version were demonstrated by Saraç et al. (2024), with Cronbach's alpha coefficients of 0.95 for the EBBS-Benefits subscale and 0.82 for the EBBS-Barriers subscale (Saraç et al., 2024).

    Time frame: At baseline and 5 days after the first assessment

Secondary outcomes

  1. Barriers to Physical Activity During Pregnancy Scale

    Developed by Amiri-Farahani et al. (2021) to evaluate barriers to physical activity among pregnant women. The scale consists of 29 items and four subdimensions, with each item scored on a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). Higher scores indicate greater barriers to physical activity (Amiri-Farahani et al., 2021). The validity and reliability of the Turkish version were confirmed by Ataman Bor and Hanligil, with Cronbach's alpha coefficients reported as follows: total scale, 0.91; pregnancy-related personal barriers, 0.88; non-pregnancy-related personal barriers, 0.89; interpersonal barriers, 0.87; environmental barriers, 0.80 (Bor \& Hanligil, 2024).

    Time frame: at baseline

  2. Pregnancy Physical Activity Questionnaire (PPAQ)

    Developed by Chasan-Taber et al. (2004), this semi-quantitative questionnaire asks participants to report the amount of time spent on 32 different activities. These include household/caregiving activities (13 items), occupational activities (5 items), sports/exercise (8 items), transportation (3 items), and inactivity (3 items). For each activity, participants indicate the amount of time they typically spend per day or week during their current trimester. Time intervals range from 0 to 6 or more hours per day and 0 to 3 or more hours per week. An open-ended section at the end allows participants to list other activities not included in the questionnaire. Weekly total energy expenditure is calculated as MET-hours/week (Chasan-Taber et al., 2004). The Turkish validity and reliability study was conducted by Çırak et al. (2015).

    Time frame: at baseline

  3. International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    Physical activity levels will be assessed using the Turkish version of the IPAQ-SF, which has demonstrated validity and reliability (Saglam et al., 2010). The questionnaire consists of seven items evaluating time spent in walking, moderate-intensity, and vigorous-intensity activities, as well as one separate question assessing time spent sitting. Scoring involves calculating total minutes and days for walking, moderate, and vigorous activities. MET-minutes are computed by multiplying the minutes spent in each activity by its MET value (vigorous activity = 8 METs, moderate activity = 4 METs, walking = 3.3 METs). Participants are classified into three categories based on total MET-minutes: "inactive," "minimally active," and "highly active" (Saglam et al., 2010).

    Time frame: at baseline

  4. Pregnancy Exercise Self-Efficacy Questionnaire

    This 10-item questionnaire assesses pregnant women's perceived ability and motivation to engage in physical activity under various circumstances. Adapted from the Exercise Self-Efficacy Scale, it was developed by Brand et al. to explain and predict changes in exercise behavior. A 5-point Likert scale is used (1 = strongly disagree to 5 = strongly agree), with total scores ranging from 10 to 50. Scores are categorized as follows: low self-efficacy, 10-17 points; moderate self-efficacy, 18-34 points; high self-efficacy, 35-50 points (Brand et al., 2013). The Turkish validity and reliability study was conducted by Üzelpasaci et al. (2023), with a Cronbach's alpha of 0.889.

    Time frame: at baseline

  5. Visual Analog Scale (VAS) for Kinesiophobia

    The severity of kinesiophobia among pregnant participants will be assessed using a vertical 0-10 cm Visual Analog Scale through the following question: • "I am afraid that exercising during pregnancy might harm my baby" (0 = not afraid at all, 10 = extremely afraid) Participants will be asked to mark a point on the VAS, and the distance from 0 will be measured with a ruler.

    Time frame: at baseline

07

Study locations

1 site
  • Ordu Üniversitesi
    Ordu, Altınordu 52000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07134959
Lead sponsor
Ordu University
Responsible party
Semiha Yenişehir (Principal Investigator, Ordu University) — Principal investigator
First posted
Aug 21, 2025
Start date
Sep 1, 2025
Primary completion
Nov 25, 2025
Completion
Dec 1, 2025
Last update
Jan 22, 2026

Study contacts

Semiha Yenişehir
principal investigator · Ordu University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion